Creatine supplementation attenuates corticosteroid-induced muscle wasting and impairment of exercise performance in rats

Journal of Applied Physiology

Volumn 102, Issue 2, 2007, Pages 698-703

  Menezes, Luciana Gomes ^a   Sobreira, Cláudia ^a   Neder, Luciano ^a   Rodrigues Jr , Antonio Luis ^a   Baddini Martinez, José A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Drug effects; Exercise tolerance; Muscular atrophy; Respiration; Steroids; Toxicity

Indexed keywords

CREATINE; DEXAMETHASONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BREATHING; COMPARATIVE STUDY; CONTROLLED STUDY; DIAPHRAGM; DIET SUPPLEMENTATION; EXERCISE; GASTROCNEMIUS MUSCLE; MALE; MUSCLE ATROPHY; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; WEIGHT GAIN; WEIGHT REDUCTION;

ADRENAL CORTEX HORMONES; ANIMALS; BODY WEIGHT; CREATINE; DEXAMETHASONE; DIAPHRAGM; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MUSCLE, SKELETAL; MUSCULAR ATROPHY; OXYGEN CONSUMPTION; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, WISTAR; RESPIRATORY MECHANICS; TIDAL VOLUME;

EID: 33846867474     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01188.2005     Document Type: Article

References (41)

1. Andrews R, Greenhaff P, Curtis S, Peny A, Cowley AJ. The effect of dietary creatine supplementation on skeletal muscle metabolism in congestive heart failure. Eur Heart J 19: 617-622, 1998.
2. Askari A, Vignos PJ Jr, Moskowitz RW. Steroid myopathy in connective tissue disease. Am J Med 61: 485-491, 1976.
3. Berneis K, Ninmis R, Haussinger D, Keller U. Effects of hyper and hypo-osmolality on whole body protein and glucose kinetics in humans. Am J Physiol Endocrinol Metab 276: E188-E195, 1999.
4. Bessman SP, Carpenter CL. The creatine-creatine phosphate energy shuttle. Annu Rev Biochem 54: 831-862, 1985.
5. Brannon TA, Adams GR, Conniff CL, Baldwin KM. Effects of creatine loading and training on running performance and biochemical properties of rat skeletal muscle. Med Sci Sports Exerc 29: 489-495, 1997.
6. Casey A, Constantin-Teodosiu D, Howell S, Hultman E, Greenhaff PL. Creatine ingestion favorably affects performance and muscle metabolism during maximal exercise in humans. Am J Physiol Endocrinol Metab 271: E31-E37, 1996.
7. Clark AF, Vignos PJ Jr. Experimental corticosteroid myopathy: effect on myofibrillar ATPase activity and protein degradation. Muscle Nerve 2: 265-273, 1979.
8. Cochran WG, Cox GM. Experimental Designs. New York: Wiley, 1950, p. 148-155.
9. Czerwinski SM, Kurowski TG, O'Neill TM, Hickson RC. Initiating regular exercise protects against muscle atrophy from glucocorticoids. J Appl Physiol 63: 1504-1510, 1987.
10. Dangott B, Schultz E, Mozalziak PE. Dietary creatine monohydrate supplementation increases satellite cell mitotic activity during compensatory hypertrophy. Int J Sports Med 21: 13-16, 2000.
11. Dubowitz V. Muscle Biopsy. A Practical Approach (2nd Ed.). London: Bailleré Tindall, 1985.
12. 31PNMR, in rats. Diabetologia 48: 328-335, 2005.
13. Falduto MT, Young AP, Hickson RC. Exercise interrupts ongoing glucocorticoid-induced muscle atrophy and glutamine synthetase induction. Am J Physiol Endocrinol Metab 263: E1157-E1163, 1992.
14. Fergunson GT, Irvin CG, Cherniack R. Effect of corticosteroids on diaphragm function and biochemistry in the rabbit. Am Rev Respir Dis 141: 156-163, 1990.
15. Ferguson GT, Irvin CG, Cherniack RM. Effect of corticosteroids on respiratory muscle histopathology. Am Rev Respir Dis 142: 1047-1052, 1990.
16. Fuld JP, Kilduff LP, Neder JA, Pitsiladis Y, Lean MEJ, Ward SA, Cotton MM. Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax 60: 531-537, 2004.
17. Gardiner PF, Edgerton VR. Contractile responses of rat fast-twitch and slow-twitch muscles to glucocorticoid treatment. Muscle Nerve 2: 274-281, 1979.
18. Gayan-Ramirez G, Vanderhoydone F, Verholven G, Decramer M. Acute treatment with corticosteroids decreases IGF-1 and IGF-2 expression in the rat diaphragm and gastrocnemius. Am J Respir Crit Care Med 159: 283-289, 1999.
19. Gordon A, Hultmann E, Kauser L, Kristjansson S, Rolf CJ, Nyquist A, Sylvén C. Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. Cardiovasc Res 30: 413-418, 1995.
20. Greenhaff P. The nutritional biochemistry of creatine. J Nutr Biochem 8: 610-618, 1997.
21. Hasselgren PO. Glucocorticoids and muscle catabolism. Curr Opin Clin Nutr Metab Care 2: 201-205, 1999.
22. Haussinger D, Lang F, Gerok W. Regulation of cell function by the cellular hydration state. Am J Physiol Endocrinol Metab 267: E343-E355, 1994.
23. Hickson RC, Czerwinski SM, Wegrzyn LE. Glutamine prevents down-regulation of myosin heavy chain synthesis and muscle atrophy from glucocorticoids. Am J Physiol Endocrinol Metab 268: E730-E734, 1995.
24. Marolda M, Padua V, Camporeale FS, Lioffi M, Orsini AV, Gentile A. Steroid miopathy: clinical and immunohistochemical study of a case. Ital J Neurol Sci 12: 409-413, 1991.
25. Max SR, Mill J, Mearow K, Konagaya M, Konagaya Y, Thomas JW, Banner C, Vitkovic L. Dexamethasone regulates glutamine synthetase expression in rat skeletal muscles. Am J Physiol Endocrinol Metab 255: E397-E402, 1988.
26. Meyer RA, Sweeney HL, Kushmerick MJ. A simple analysis of the "phosphocreatine shuttle". Am J Physiol Cell Physiol 246: C365-C377, 1984.
27. Mihic S, MacDonald R, McKenzie S, Tarnopolsky MA. Acute creatinine loading increases fat-free mass, but does not affect blood pressure, plasma creatine, or CK activity in men and women. Med Sci Sports Exerc 32: 291-296, 2000.
28. Mitsui T, Ozuma H, Nagasawa M, Iuchi T, Akaike M, Odorni M, Matsumoto T. Chronic corticosteroid administration causes mitochondrial dysfunction in skeletal muscle. J Neurol 249: 1004-1009, 2002.
29. Montgomery DC. Design and Analysis of Experiments. New York: Wiley, 1997, p. 290-301.
30. Nissen SL, Sharp RL. Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis. J Appl Physiol 94: 651-659, 2003.
31. Owczarek J, Jasinska M, and Orszulak-Michalak D. Drug-induced myopathies. An overview of possible mechanisms. Pharmacol Rep 57: 23-34, 2005.
32. Parise G, Mihic S, MacLennan D, Yarasheski KE, Tarnopolsky MA. Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed muscle protein synthesis. J Appl Physiol 91: 1041-1047, 2001.
33. Rawson E, Gunn B, Clarkson P. The effects of creatine supplementation on exercise-induced muscle damage. J Strength Cond Res 15: 178-184, 2001.
34. Roy BD, Bourgeois JM, Mahoney DJ, Tarnopolsky MA. Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats. Can J Physiol Pharmacol 80: 1008-1014, 2002.
35. Sharov VG, Sacks VA, Kupriyanov VV, Lakomkin VL, Kapelko V, Steinschneider A, Javadov SA. Protection of ischemic myocardium by exogenous phosphocreatine. I. Morphologic and phosphorus 31-nuclear magnetic resonance studies. J Thorac Cardiovasc Surg 94: 749-761, 1987.
36. Singleton JR, Baker BL, Thorburn A. Dexamethasone inhibits insulinlike growth factor signaling and potentiates myoblast apoptosis. Endocrinology 141: 2945-2950, 2000.
37. Singleton JR, Dixit VM, Feldman EL. Type I insulin-like growth factor receptor activation regulates apoptotic proteins. J Biol Chem 271: 31791-31794, 1996.
38. Tarnopolsky MA, Martin J. Creatine monohydrate increases strength in patients with neuromuscular diseases. Neurology 52: 854-857, 1999.
39. Tarnopolsky MA, Mahoney DJ, Vajsar J, Rodriguez C, Doherty DJ, Roy BD, Biggar D. Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy. Neurology 62: 1771-1777, 2004.
40. Williams MH, Branch JD. Creatine supplementation and exercise performance: an update. J Am Coll Nutr 17: 216-234, 1998.
41. Volek JS, Duncan ND, Mazzetti SA, Staron RS, Putukian M, Gomez AL, Pearson DR, Fink WJ, Kraemer WJ. Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training. Med Sci Sports Exerc 31: 1147-1156, 1999.